Health
-
A.L.S. Drug Relyvrio Fails Clinical Trial and May Be Withdrawn From the Market
Leaders of the treatment’s manufacturer, Amylyx, said they would announce their plans for it within eight weeks.
-
Female Genital Cutting Continues to Increase Worldwide
Campaigns in some countries have reduced the practice, but it remains widespread in those with high rates of population growth.
-
Weeks of Stress, Confusion for I.V.F. Patients in Alabama
Many suffered setbacks after the state supreme court ruled that frozen embryos were children. “Someone else’s opinion changed my future,”…
-
F.D.A. Urges Recall of Cinnamon Brands Tainted by Lead
The agency tested 75 types of cinnamon after hundreds of children were poisoned by the spice in applesauce. It found…
-
Top Senators Urge Stores to Stop Selling Illicit Vapes
Lawmakers want shopkeepers to remove e-cigarettes that were not authorized by the F.D.A. Retailers say it is not that simple.
-
One Twin Was Hurt, the Other Was Not. Their Adult Mental Health Diverged.
A large study of “discordant twins,” in which only one suffered abuse or neglect, adds to evidence linking childhood trauma…
-
After 217 Covid Vaccines, Man Had No Side Effects and Robust Immunity
Media accounts of a German man’s extreme vaccination history spurred researchers to analyze his immune responses.
-
Alabama Bill to Protect I.V.F. Will Reopen Clinics but Curb Patient Rights
Here’s what to know about the legislation, which the state legislature is expected to approve overwhelmingly on Wednesday.
-
Cyberattack Paralyzes the Largest U.S. Health Care Payment System
The hacking shut down the nation’s biggest health care payment system, causing financial chaos that affected a broad spectrum ranging…
-
Powerful Psychedelic Gains Renewed Attention as a Treatment for Opioid Addiction
Ibogaine, a formidable hallucinogen made from the root of a shrub native to Central Africa, is not for the timid.…